These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2872956)

  • 1. GABA-agonist therapy for Alzheimer's disease.
    Mohr E; Bruno G; Foster N; Gillespie M; Cox C; Hare TA; Tamminga C; Fedio P; Chase TN
    Clin Neuropharmacol; 1986; 9(3):257-63. PubMed ID: 2872956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THIP treatment of Huntington's disease.
    Foster NL; Chase TN; Denaro A; Hare TA; Tamminga CA
    Neurology; 1983 May; 33(5):637-9. PubMed ID: 6221200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist.
    Christensen AV; Svendsen O; Krogsgaard-Larsen P
    Pharm Weekbl Sci; 1982 Oct; 4(5):145-53. PubMed ID: 6292818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4,5,6,7-Tetrahydroisothiazolo[5,4-c]pyridin-3-ol and related analogues of THIP. Synthesis and biological activity.
    Krogsgaard-Larsen P; Mikkelsen H; Jacobsen P; Falch E; Curtis DR; Peet MJ; Leah JD
    J Med Chem; 1983 Jun; 26(6):895-900. PubMed ID: 6304315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
    Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
    Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
    Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
    Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THIP: a single-blind controlled trial in patients with epilepsy.
    Petersen HR; Jensen I; Dam M
    Acta Neurol Scand; 1983 Feb; 67(2):114-7. PubMed ID: 6845976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
    Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN
    Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the responses to the GABA-mimetics, THIP and piperidine-4-sulphonic acid, by agents which interact with benzodiazepine receptors. An electrophysiological study on cultured mouse neurones.
    Jensen MS; Lambert JD
    Neuropharmacology; 1984 Dec; 23(12A):1441-50. PubMed ID: 6098852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of GABA, THIP, and potassium on excitability of myelinated axons of isolated amphibian spinal roots.
    Liske S; Morris ME
    Can J Physiol Pharmacol; 1989 Jun; 67(6):682-5. PubMed ID: 2789093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the GABA-A agonist THIP on regional cortical blood flow in humans. A new test of hemispheric dominance.
    Roland PE; Friberg L
    J Cereb Blood Flow Metab; 1988 Jun; 8(3):314-23. PubMed ID: 3366794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of the GABA agonist [3H]THIP to rat brain synaptic membranes.
    Falch E; Krogsgaard-Larsen P
    J Neurochem; 1982 Apr; 38(4):1123-9. PubMed ID: 6278083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for inhibitory effect of the agonist gaboxadol at human alpha 1 beta 2 gamma 2S GABAA receptors.
    Smith M; Lindquist CE; Birnir B
    Eur J Pharmacol; 2003 Sep; 478(1):21-6. PubMed ID: 14555180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic localization of binding sites for the gamma-aminobutyric acid analogues 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP)isoguvacine and baclofen on cultured neurons of rat cerebellum and spinal cord.
    Hösli E; Krogsgaard-Larsen P; Hösli L
    Neurosci Lett; 1985 Oct; 61(1-2):153-7. PubMed ID: 3001590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAergic actions of THIP in vivo and vitro: a comparison with muscimol and GABA.
    Waszczak BL; Hruska RE; Walters JR
    Eur J Pharmacol; 1980 Jul; 65(1):21-9. PubMed ID: 7398775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing anesthesia with a GABA analog, THIP.
    Cheng SC; Brunner EA
    Anesthesiology; 1985 Aug; 63(2):147-51. PubMed ID: 3161425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant activity of intracerebroventricularly administered glial GABA uptake inhibitors and other GABAmimetics in chemical seizure models.
    Gonsalves SF; Twitchell B; Harbaugh RE; Krogsgaard-Larsen P; Schousboe A
    Epilepsy Res; 1989; 4(1):34-41. PubMed ID: 2526732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inhibitors of protein synthesis and intracellular transport on the gamma-aminobutyric acid agonist-induced functional differentiation of cultured cerebellar granule cells.
    Belhage B; Hansen GH; Meier E; Schousboe A
    J Neurochem; 1990 Oct; 55(4):1107-13. PubMed ID: 2168931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazepam enhances the action but not the binding of the GABA analog, THIP.
    Skerritt JH; Macdonald RL
    Brain Res; 1984 Apr; 297(1):181-6. PubMed ID: 6722533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic failure of GABA agonist treatment in Huntington's disease.
    Waddington JL; Cross AJ
    Neurology; 1984 May; 34(5):702. PubMed ID: 6231490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.